1. Bacterial translocation markers in liver cirrhosis.
Alexopoulou A, Agiasotelli D, Vasilieva LE, Dourakis SP.
Ann Gastroenterol. 2017;30(5):486-497. doi: 10.20524/aog.2017.0178. Epub 2017 Jul 25.PMID: 28845103 Free PMC article. Review.
2. Fungal infections in patients with cirrhosis.
Alexopoulou A, Vasilieva L, Agiasotelli D, Dourakis SP.
J Hepatol. 2015 Oct;63(4):1043-5. doi: 10.1016/j.jhep.2015.05.032. Epub 2015 Jun 19.PMID: 26095180 No abstract available.
3. Response to Lipopolysaccharide binding protein predicts decompensated cirrhosis mortality? It is too early.
Agiasotelli D, Alexopoulou A, Vasilieva L, Hadziyannis E, Goukos D, Daikos GL, Dourakis SP.
Liver Int. 2017 Jul;37(7):1085-1086. doi: 10.1111/liv.13313.PMID: 28635167 No abstract available.
4. Reply to “Prognosis of cirrhotic patients with fungiascites and spontaneous fungal peritonitis”.
Alexopoulou A, Vasilieva L, Agiasotelli D, Dourakis SP.
J Hepatol. 2016 Jun;64(6):1454-5. doi: 10.1016/j.jhep.2016.02.014. Epub 2016 Feb 22.PMID: 26907974 No abstract available.
5. Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure.
Mani I, Alexopoulou A, Vasilieva L, Hadziyannis E, Agiasotelli D, Bei M, Alexopoulos T, Dourakis SP.
Liver Int. 2019 Feb;39(2):299-306. doi: 10.1111/liv.13977. Epub 2018 Oct 24.PMID: 30261128
6. Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure.
Agiasotelli D, Alexopoulou A, Vasilieva L, Dourakis SP.
J Hepatol. 2014 Dec;61(6):1446-7. doi: 10.1016/j.jhep.2014.06.042. Epub 2014 Sep 6. PMID: 25200906 Free article. No abstract available.
7. Soluble CD146, a novel endothelial marker, is related to the severity of liver disease.
Nomikou E, Alexopoulou A, Vasilieva L, Agiasotelli D, Pavlou E, Theodossiades G, Dourakis SP.
Scand J Gastroenterol. 2015 May;50(5):577-83. doi: 10.3109/00365521.2014.985706. Epub 2015 Jan 30.PMID: 25636502
8. High serum lipopolysaccharide binding protein is associated with increased mortality in patients with decompensated cirrhosis.
Agiasotelli D, Alexopoulou A, Vasilieva L, Hadziyannis E, Goukos D, Daikos GL, Dourakis SP.
Liver Int. 2017 Apr;37(4):576-582. doi: 10.1111/liv.13264. Epub 2016 Oct 31.PMID: 27712029
9. Single center validation of mortality scores in patients with acute decompensation of cirrhosis with and without acute-on-chronic liver failure.
Alexopoulou A, Vasilieva L, Mani I, Agiasotelli D, Pantelidaki H, Dourakis SP.
Scand J Gastroenterol. 2017 Dec;52(12):1385-1390. doi: 10.1080/00365521.2017.1369560. Epub 2017 Aug 29.PMID: 28851246
10. Evaluation of neutrophil/leukocyte ratio and organ failure score as predictors of reversibility and survival following an acute-on-chronic liver failure event.
Agiasotelli D, Alexopoulou A, Vasilieva L, Kalpakou G, Papadaki S, Dourakis SP.
Hepatol Res. 2016 May;46(6):514-20. doi: 10.1111/hepr.12582. Epub 2015 Oct 6.PMID: 26331309
11. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.
Alexopoulou A, Vasilieva L, Agiasotelli D, Siranidi K, Pouriki S, Tsiriga A, Toutouza M, Dourakis SP.
World J Gastroenterol. 2016 Apr 21;22(15):4049-56. doi: 10.3748/wjg.v22.i15.4049.PMID: 27099449 Free PMC article.